Joshua D Palmer, Tejash T Patel, Harriet Eldredge-Hindy, Scott W Keith, Tapas Patel, Theresa Malatesta, Jessie DiNome, Anne Lowther, Linda Ferguson, Sally Wagenborg, John Smyles, Usha Babaria, Richard Stabile, Eric Gressen, Shari Rudoler, Scot A Fisher
PURPOSE: Little is known about the financial burden experienced by patients receiving radiation therapy. Furthermore, currently, no financial toxicity screening tools have been validated for use in radiation oncology. METHODS AND MATERIALS: Physician surveys were used to gauge provider understanding of treatment costs and their willingness to adopt the use of financial toxicity screening tools. Post-treatment patient surveys were used to investigate the covariates of treatment-induced financial risk...
June 1, 2018: International Journal of Radiation Oncology, Biology, Physics